ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,249,903 | +83.8% | 52,188 | +44.5% | 0.06% | +122.2% |
| Q1 2023 | $679,891 | -69.0% | 36,126 | -73.7% | 0.03% | -66.2% |
| Q4 2022 | $2,189,876 | -48.2% | 137,555 | -46.7% | 0.08% | -46.3% |
| Q3 2022 | $4,226,000 | +1610.9% | 258,297 | +1371.3% | 0.15% | +2028.6% |
| Q2 2022 | $247,000 | -60.3% | 17,556 | -34.1% | 0.01% | -70.8% |
| Q4 2021 | $622,000 | +67.2% | 26,637 | +18.8% | 0.02% | +71.4% |
| Q3 2021 | $372,000 | -91.1% | 22,426 | -86.1% | 0.01% | -89.2% |
| Q1 2021 | $4,177,000 | +21.8% | 161,892 | +152.4% | 0.13% | +14.0% |
| Q4 2020 | $3,429,000 | – | 64,134 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |